GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Majzner, RG; Ramakrishna, S; Yeom, KW; Patel, S; Chinnasamy, H; Schultz, LM; Richards, RM; Jiang, L; Barsan, V; Mancusi, R; et al.
Nature.
2022;
603:934-941.
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.
Lee, AH; Sun, L; Mochizuki, AY; Reynoso, JG; Orpilla, J; Chow, F; Kienzler, JC; Everson, RG; Nathanson, DA; Bensinger, SJ; et al.
Nature Communications.
2021;
12.
A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
Minturn, JE; Mochizuki, AY; Partap, S; Belasco, JB; Lange, BJ; Li, Y; Phillips, PC; Gibbs, IC; Fisher, PG; Fisher, MJ; et al.
Frontiers in Oncology.
2021;
11.
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Ladomersky, E; Zhai, L; Lauing, KL; Bell, A; Xu, J; Kocherginsky, M; Zhang, B; Wu, JD; Podojil, JR; Platanias, LC; et al.
Clinical Cancer Research.
2020;
26:5232-5245.
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation.
Davidson, TB; Lee, A; Hsu, M; Sedighim, S; Orpilla, J; Treger, J; Mastall, M; Roesch, S; Rapp, C; Galvez, M; et al.
Clinical Cancer Research.
2019;
25:1913-1922.
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Cloughesy, TF; Mochizuki, AY; Orpilla, JR; Hugo, W; Lee, AH; Davidson, TB; Wang, AC; Ellingson, BM; Rytlewski, JA; Sanders, CM; et al.
Nature Medicine.
2019;
25:477-486.
Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients.
Owens, GC; Garcia, AJ; Mochizuki, AY; Chang, JW; Reyes, SD; Salamon, N; Prins, RM; Mathern, GW; Fallah, A.
Frontiers in Immunology.
2019;
10.
Precision Medicine in Pediatric Neurooncology: A Review.
Mochizuki, AY; Frost, IM; Mastrodimos, MB; Plant, AS; Wang, AC; Moore, TB; Prins, RM; Weiss, PS; Jonas, SJ.
ACS Chemical Neuroscience.
2018;
9:11-28.